19.14
Legend Biotech Corp Adr Borsa (LEGN) Ultime notizie
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Legend Biotech (LEGN) Q2 2025 Earnings Transcript - The Globe and Mail
Legend Biotech Corporation Sponsored ADR $LEGN Shares Bought by SG Americas Securities LLC - MarketBeat
Legend Biotech (NASDAQ:LEGN) CEO Sells $87,138.72 in Stock - MarketBeat
Huang Ying, CEO of Legend Biotech, sells $87k in shares - Investing.com India
Recent Research Analysts’ Ratings Updates for Legend Biotech (LEGN) - Defense World
Virtus Biotech ETF Holdings - Quiver Quantitative
Hudson Bay Capital Management LP Has $7.17 Million Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech Q1 EPS Estimate Decreased by HC Wainwright - MarketBeat
Q2 EPS Estimates for Legend Biotech Lowered by HC Wainwright - MarketBeat
Braidwell LP Decreases Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
ArrowMark Colorado Holdings LLC Cuts Position in Axis Capital Holdings Limited $AXS - Defense World
UiPath (NYSE:PATH) Price Target Cut to $13.00 by Analysts at Wells Fargo & Company - Defense World
Capital International Investors Sells 140,873 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
iShares MBS ETF $MBB Shares Acquired by Capital International Investors - Defense World
CLEAR Secure, Inc. (NYSE:YOU) Receives Average Recommendation of “Hold” from Analysts - Defense World
Royal Bank Of Canada Lowers Legend Biotech (NASDAQ:LEGN) Price Target to $62.00 - Defense World
Legend Biotech Plans to List in HK as Early as This Yr, Raising at Least US$300M: Wire - AASTOCKS.com
RBC Capital lowers Legend Biotech stock price target on model updates By Investing.com - Investing.com South Africa
RBC Capital lowers Legend Biotech stock price target on model updates - Investing.com India
Legend Biotech Q4 2025 slides: CARVYKTI turns profitable, $555M sales By Investing.com - Investing.com South Africa
Raymond James reiterates Legend Biotech stock rating on strong Q4 results - Investing.com India
Truist reiterates Buy on Legend Biotech stock, $70 target on capacity - Investing.com
Jefferies reiterates Legend Biotech stock rating on Carvykti sales - Investing.com India
Jefferies reiterates Legend Biotech stock rating on Carvykti sales By Investing.com - Investing.com South Africa
Legend Biotech Q4 Earnings Call Highlights - Yahoo Finance
Legend Biotech Q4 2025 slides: CARVYKTI turns profitable, $555M sales - Investing.com India
Earnings call transcript: Legend Biotech Q4 2025 shows strong growth By Investing.com - Investing.com India
Earnings call transcript: Legend Biotech Q4 2025 shows strong growth - Investing.com
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Legend Biotech earnings on deck as profitability looms - Investing.com South Africa
Triata Capital Ltd Purchases 54,300 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Raymond James reiterates Legend Biotech stock rating after rival approval - Investing.com South Africa
Legend Biotech (NASDAQ:LEGN) Trading Up 5.5%Here's Why - MarketBeat
Artisan Partners Limited Partnership Purchases 425,684 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Westfield Capital Management Co. LP Lowers Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Nuclear Stocks To Research – February 23rd - Defense World
Raymond James reiterates Legend Biotech stock rating on valuation gap - Investing.com South Africa
Etsy (NYSE:ETSY) Stock Price Up 6.6% on Earnings Beat - Defense World
Barclays Cite Favorable Long-Term Outlook For Legend Biotech Corporation (LEGN) Despite Near-Term Expectation Revisions - Finviz
FDA Guidance on MRD Negativity Bodes Well for Legend Biotech (LEGN) - Finviz
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Legend Biotech (NASDAQ:LEGN) Downgraded by Rothschild & Co Redburn to “Neutral” - Defense World
Legend Biotech stock rating downgraded by Rothschild Redburn on competition concerns By Investing.com - Investing.com India
Legend Biotech stock rating downgraded by Rothschild Redburn on competition concerns - Investing.com
Legend Biotech (NASDAQ:LEGN) Makes Strides in Nasdaq Composite Biotech Field - kalkinemedia.com
Investment Analysts’ Weekly Ratings Updates for Legend Biotech (LEGN) - Defense World
Legend Biotech (LEGN) Shakes Up Board - Finviz
Legend Biotech (NASDAQ:LEGN) Sets New 12-Month LowTime to Sell? - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):